Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Managing HER2-positive breast cancer

BGICC 2021

21 - 22 Jan 2021

Published: 16 Feb 2021

Views: 924

Rating:

Save

Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA

Prof Monica Morrow speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about managing patients with HER2-positive breast cancer.

She speaks about the benefits of neo-adjuvant therapies for these patients, giving her practical advice for management strategies and discussing recent relevant research.

Related Videos

Neo-adjuvant therapy for different cancers in the Philippines

Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines

Neo-adjuvant therapy for different cancers in the Philippines ( Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines )

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

The role of lymph nodes in stage 3 lung cancer

Prof Walter Weder - Privatklinik Bethanien,Zürich, Switzerland

The role of lymph nodes in stage 3 lung cancer ( Prof Walter Weder - Privatklinik Bethanien,Zürich, Switzerland )

The role of multidisciplinary tumour board in managing stage 3 lung cancer

Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland

The role of multidisciplinary tumour board in managing stage 3 lung cancer ( Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland )

COMMENT: Women Who Conquer Cancer

Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia

COMMENT: Women Who Conquer Cancer ( Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia )

Cancer pain management

Prof Ebtesam Ahmed - St John's University New York, New York City, USA

Cancer pain management ( Prof Ebtesam Ahmed - St John's University New York, New York City, USA )

Developments in breast reconstructive surgery

Dr Maria João Cardoso - Champalimaud Cancer Centre, Lisbon, Portugal

Developments in breast reconstructive surgery ( Dr Maria João Cardoso - Champalimaud Cancer Centre, Lisbon, Portugal )

Moving to the future: Artificial intelligence in surgery

Dr Maria João Cardoso - Champalimaud Cancer Centre, Lisbon, Portugal

Moving to the future: Artificial intelligence in surgery ( Dr Maria João Cardoso - Champalimaud Cancer Centre, Lisbon, Portugal )

Comment: LUMINA results show that women with low levels of the Ki67 biomarker...

Dr Corey Wayne Speers - University of Michigan, Ann Arbor, USA

Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy ( Dr Corey Wayne Speers - University of Michigan, Ann Arbor, USA )

More from ecancer